IP Library Granted Patent US 7,981,858
Granted Patent B1
US 7,981,858 · App. 12/782,057 · Granted Jul 19, 2011

Methods of using zinc containing compounds to improve ocular health

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,981,858
App. No.
12/782,057
Granted
Jul 19, 2011
Kind
B1
Abstract

The present invention provides zinc complexes for use in methods of providing zinc to subjects in need of treatment. The invention further provides improved dietary supplement formulations for improving and maintaining ocular nutrition. In particular, the improved dietary supplement formulations comprise the zinc complexes described herein, antioxidant vitamins, minerals and excipients.

Claims (9)

1. A method of providing zinc to a subject suffering from or at risk for developing macular degeneration, said method comprising administering to the subject an effective amount of a composition comprising a zinc-glutathione complex having the formula

2. The method of claim 1 , wherein the amount of zinc-glutathione complex contained in the composition contains from 15 to 100 mg bioavailable zinc.

3. The method of claim 1 , wherein the composition further comprises vitamin A, vitamin C, vitamin E and copper.

4. The method of claim 3 , wherein the composition further comprises docosahexaenoic acid (DHA).

5. The method of claim 1 , wherein the composition is in a form selected from the group consisting of a powder, capsule, caplet, gel cap, and tablet.

6. The method of claim 5 , wherein the composition is a tablet.

7. The method of claim 1 , wherein the composition further comprises copper.

8. The method of claim 7 , wherein the amount of copper in the composition is from about 0.4 mg to about 4 mg.

9. The method of claim 8 , wherein the amount of zinc-glutathione complex in the composition is about 80 mg.

Assignments (1)
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →